Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy SELLAS Life Sciences Group stock | $6.97
Own SELLAS Life Sciences Group stock in just a few minutes.
Fact checked
SELLAS Life Sciences Group, Inc is a biotechnology business based in the US. SELLAS Life Sciences Group shares (SLS) are listed on the NASDAQ and all prices are listed in US Dollars. SELLAS Life Sciences Group employs 5 staff and has a market cap (total outstanding shares value) of USD$81.5 million.
How to buy shares in SELLAS Life Sciences Group
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for SELLAS Life Sciences Group. Find the stock by name or ticker symbol: SLS. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until SELLAS Life Sciences Group reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of USD$6.97, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of SELLAS Life Sciences Group, depending on your broker.
- Check in on your investment. Congratulations, you own a part of SELLAS Life Sciences Group. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- SLS shares summary
- Compare share dealing platforms
- Is SLS stock a buy or sell?
- Stock performance over time
- Can I short SLS shares?
- Are SLS shares over-valued?
- SELLAS Life Sciences Group's financials
- How volatile are SLS shares?
- Does SELLAS Life Sciences Group pay a dividend?
- Have SLS shares ever split?
- Other common questions
SELLAS Life Sciences Group share price
Use our graph to track the performance of SLS stocks over time.SELLAS Life Sciences Group shares at a glance
Information last updated 2020-12-29.
| Latest market close | USD$6.97 |
|---|---|
| 52-week range | USD$1.455 - USD$8.58 |
| 50-day moving average | USD$4.9212 |
| 200-day moving average | USD$3.2954 |
| Wall St. target price | USD$10 |
| PE ratio | 0.6181 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-1.351 |
Buy SELLAS Life Sciences Group shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy SELLAS Life Sciences Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
SELLAS Life Sciences Group price performance over time
Historical closes compared with the close of $6.97 from 2020-12-18
| 1 week (2021-01-13) | N/A |
|---|---|
| 1 month (2020-12-24) | 10.46% |
| 3 months (2020-10-20) | N/A |
| 6 months (2020-07-20) | N/A |
| 1 year (2020-01-20) | N/A |
|---|---|
| 2 years (2019-01-20) | N/A |
| 3 years (2018-01-20) | N/A |
| 5 years (2016-01-20) | N/A |
Is SELLAS Life Sciences Group under- or over-valued?
Valuing SELLAS Life Sciences Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of SELLAS Life Sciences Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
SELLAS Life Sciences Group's P/E ratio
SELLAS Life Sciences Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, SELLAS Life Sciences Group shares trade at around 1x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
SELLAS Life Sciences Group financials
| Gross profit TTM | USD$0 |
|---|---|
| Return on assets TTM | -54.6% |
| Return on equity TTM | -220.18% |
| Profit margin | 0% |
| Book value | $0.84 |
| Market capitalisation | USD$81.5 million |
TTM: trailing 12 months
Shorting SELLAS Life Sciences Group shares
There are currently 1.3 million SELLAS Life Sciences Group shares held short by investors – that's known as SELLAS Life Sciences Group's "short interest". This figure is 127.4% up from 553,845 last month.
There are a few different ways that this level of interest in shorting SELLAS Life Sciences Group shares can be evaluated.
SELLAS Life Sciences Group's "short interest ratio" (SIR)
SELLAS Life Sciences Group's "short interest ratio" (SIR) is the quantity of SELLAS Life Sciences Group shares currently shorted divided by the average quantity of SELLAS Life Sciences Group shares traded daily (recently around 10.5 million). SELLAS Life Sciences Group's SIR currently stands at 0.12. In other words for every 100,000 SELLAS Life Sciences Group shares traded daily on the market, roughly 120 shares are currently held short.
However SELLAS Life Sciences Group's short interest can also be evaluated against the total number of SELLAS Life Sciences Group shares, or, against the total number of tradable SELLAS Life Sciences Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case SELLAS Life Sciences Group's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 SELLAS Life Sciences Group shares in existence, roughly 110 shares are currently held short) or 0.1061% of the tradable shares (for every 100,000 tradable SELLAS Life Sciences Group shares, roughly 106 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against SELLAS Life Sciences Group.
Find out more about how you can short SELLAS Life Sciences Group stock.
SELLAS Life Sciences Group share dividends
We're not expecting SELLAS Life Sciences Group to pay a dividend over the next 12 months.
Have SELLAS Life Sciences Group's shares ever split?
SELLAS Life Sciences Group's shares were split on a 1:50 basis on 8 November 2019. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your SELLAS Life Sciences Group shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for SELLAS Life Sciences Group shares which in turn could have impacted SELLAS Life Sciences Group's share price.
SELLAS Life Sciences Group share price volatility
Over the last 12 months, SELLAS Life Sciences Group's shares have ranged in value from as little as $1.455 up to $8.58. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SELLAS Life Sciences Group's is 1.6821. This would suggest that SELLAS Life Sciences Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
SELLAS Life Sciences Group overview
SELLAS Life Sciences Group, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a wilms tumor 1 targeting peptide-based cancer immunotherapeutic agent, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and is in various development phases as a potential treatment for ovarian cancer. It also develops nelipepimut-S that is in Phase 2b clinical trials for the treatment of breast cancer. The company has strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors. SELLAS Life Sciences Group, Inc. was founded in 2012 and is headquartered in New York, New York.
Frequently asked questions
More guides on Finder
-
How to buy SS-and-C Technologies stock | $64.53
Steps to owning and managing SSNC, with 24-hour and historical pricing before you buy.
-
How to buy Southern Missouri Bancorp stock
Steps to owning and managing SMBC, with 24-hour and historical pricing before you buy.
-
How to buy Sharps Compliance stock
Steps to owning and managing SMED, with 24-hour and historical pricing before you buy.
-
How to buy SJW Group stock
Steps to owning and managing SJW, with 24-hour and historical pricing before you buy.
-
How to buy ServisFirst Bancshares stock
Steps to owning and managing SFBS, with 24-hour and historical pricing before you buy.
-
How to buy SemiLEDs Corporation stock
Steps to owning and managing LEDS, with 24-hour and historical pricing before you buy.
-
How to buy Santander Consumer USA stock
Steps to owning and managing SC, with 24-hour and historical pricing before you buy.
-
How to buy RTW Retailwinds stock
Steps to owning and managing RTW, with 24-hour and historical pricing before you buy.
-
How to buy Riverview Financial Corporation stock
Steps to owning and managing RIVE, with 24-hour and historical pricing before you buy.
-
How to buy Riverview Bancorp stock
Steps to owning and managing RVSB, with 24-hour and historical pricing before you buy.
Ask an Expert